关注
Marjolaine Debant
Marjolaine Debant
在 leeds.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Shear stress activates ADAM10 sheddase to regulate Notch1 via the Piezo1 force sensor in endothelial cells
V Caolo, M Debant, N Endesh, TS Futers, L Lichtenstein, F Bartoli, ...
Elife 9, e50684, 2020
652020
Orai1 Channel Inhibition Preserves Left Ventricular Systolic Function and Normal Ca2+ Handling After Pressure Overload
F Bartoli, MA Bailey, B Rode, P Mateo, F Antigny, K Bedouet, P Gerbaud, ...
Circulation 141 (3), 199-216, 2020
542020
CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes
S Garaud, TE Taher, M Debant, M Burgos, S Melayah, C Berthou, ...
Cellular & molecular immunology 15 (2), 158-170, 2018
532018
Calcium signaling: from normal B cell development to tolerance breakdown and autoimmunity.
P Hemon, Y Renaudineau, M Debant, N Le Goux, S Mukherjee, W Brooks, ...
Clinical Reviews in Allergy & Immunology 53, 141-165, 2017
512017
Constitutive calcium entry and cancer: updated views and insights
O Mignen, B Constantin, M Potier-Cartereau, A Penna, M Gautier, ...
European Biophysics Journal 46, 395-413, 2017
492017
Endothelial Piezo1 sustains muscle capillary density and contributes to physical activity
F Bartoli, M Debant, E Chuntharpursat-Bon, EL Evans, KE Musialowski, ...
The Journal of clinical investigation 132 (5), 2022
412022
PIEZO1 and PECAM1 interact at cell-cell junctions and partner in endothelial force sensing
E Chuntharpursat-Bon, OV Povstyan, MJ Ludlow, DJ Carrier, M Debant, ...
Communications Biology 6 (1), 358, 2023
362023
Calcium signaling and cell fate: how can Ca2+ signals contribute to wrong decisions for chronic lymphocytic leukemic B lymphocyte outcome
M Debant, P Hemon, C Brigaudeau, Y Renaudineau, O Mignen
Int J Dev Biol 59 (7-9), 379-89, 2015
282015
Improved PIEZO1 agonism through 4‐benzoic acid modification of Yoda1
G Parsonage, K Cuthbertson, N Endesh, N Murciano, AJ Hyman, ...
British Journal of Pharmacology 180 (16), 2039-2063, 2023
232023
Placental blood flow sensing and regulation in fetal growth restriction
LC Morley, M Debant, JJ Walker, DJ Beech, NAB Simpson
Placenta 113, 23-28, 2021
232021
STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia
M Debant, M Burgos, P Hemon, P Buscaglia, T Fali, S Melayah, ...
Journal for immunotherapy of cancer 7, 1-13, 2019
182019
Ofatumumab capacity to deplete B cells from chronic lymphocytic leukaemia is affected by C4 complement exhaustion
A Tempescul, C Bagacean, C Riou, B Bendaoud, S Hillion, M Debant, ...
European Journal of Haematology 96 (3), 229-235, 2016
182016
Global PIEZO1 gain-of-function mutation causes cardiac hypertrophy and fibrosis in mice
F Bartoli, EL Evans, NM Blythe, L Stewart, E Chuntharpursat-Bon, ...
Cells 11 (7), 1199, 2022
142022
Molecular dynamics simulations of membrane-bound STIM1 to investigate conformational changes during STIM1 activation upon calcium release
S Mukherjee, A Karolak, M Debant, P Buscaglia, Y Renaudineau, ...
Journal of Chemical Information and Modeling 57 (2), 335-344, 2017
72017
Cx43 present at the leading edge membrane governs promigratory effects of osteoblast-conditioned medium on human prostate cancer cells in the context of bone metastasis
J Boucher, AC Balandre, M Debant, J Vix, T Harnois, N Bourmeyster, ...
Cancers 12 (10), 3013, 2020
62020
Nitric oxide synthase phosphorylation in fetoplacental endothelium is enhanced by agonism of Piezo1 mechanosensor in small for gestational age babies
LC Morley, M Debant, HJ Gaunt, NAB Simpson, DJ Beech
Reproduction and Fertility 4 (1), 2023
12023
Pharmacology of PIEZO1 channels
J Kinsella, M Debant, G Parsonage, L Morley, M Bajarwan, C Revill, ...
British Journal of Pharmacology, 2024
2024
Monoclonal antibody against stim1
O Mignen, Y Renaudineau, M Debant, P Hemon
US Patent App. 17/442,636, 2023
2023
Monoclonal antibody against stim1
O Mignen, Y Renaudineau, M Debant, P Hemon
US Patent App. 17/442,638, 2023
2023
Processes for the diagnosis, prognosis and monitoring of the progression of chronic lymphoid leukaemia (CLL) and/or of systemic lupus erythematosus (SLE) using membrane STIM 1
Y Renaudineau, O Mignen, M Debant, C Le Dantec, JO Pers
US Patent 11,231,418, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–20